Risk-Stratification Of B-Precursor Acute Lymphoblastic Leukemia Patients
Patent No. EP3531133 (titled "Risk-Stratification Of B-Precursor Acute Lymphoblastic Leukemia Patients") was filed by Amgen on May 20, 2015. The application was issued on Aug 23, 2023.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3531133
- Application Number
- EP18213926A
- Filing Date
- May 20, 2015
- Status
- Revoked
- Jan 24, 2025
- Publication Date
- Aug 23, 2023
- External Links
- Slate, Register , Google Patents